Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Operating Expenses (2010 - 2026)

Updated

Bioxytran (BIXT) posted Operating Expenses of $654,600 for Q2 2026, up 192.1% from $224,077 a year earlier but down 66.1% from the prior quarter.

Analysis

Bioxytran (BIXT) Operating Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Bioxytran was $3.69 million, up 134.5% year-over-year; for FY2025, it came in at $1.84 million, down 17.1% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
  • In prior years, Bioxytran's Operating Expenses was $2.22 million in FY2024 (-41.5%), $3.8 million in FY2023 (+56.0%), $2.44 million in FY2022 (-42.2%) and $4.21 million in FY2021 (+232.2%).
  • Quarterly Operating Expenses has run from a low of -$14,225 in Q3 2022 to a high of $1.93 million in Q1 2026 over five years.
  • On a year-over-year basis, Operating Expenses has increased in each of the last four quarters, with growth averaging 40.2% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q3 2021, with growth of 378.2%; the weakest was Q3 2024, with a decline of 64.9%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $1.93 million (Q1 2026), $607,285 (Q4 2025) and $496,005 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Bioxytran 2.29 Mn 1.13 Mn - 654,600.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 654,600.00
Mar 31, 2026 1.93 Mn
Dec 31, 2025 607,285.00
Sep 30, 2025 496,005.00
Jun 30, 2025 224,077.00
Mar 31, 2025 515,142.00
Dec 31, 2024 488,313.00
Sep 30, 2024 346,204.00
Jun 30, 2024 609,322.00
Mar 31, 2024 779,229.00
Dec 31, 2023 1.01 Mn
Sep 30, 2023 985,465.00
Jun 30, 2023 1.06 Mn
Mar 31, 2023 750,242.00
Dec 31, 2022 1.09 Mn
Sep 30, 2022 -14,225.00
Jun 30, 2022 537,224.00
Mar 31, 2022 819,106.00
Dec 31, 2021 935,964.00
Sep 30, 2021 547,243.00
API Access

Bioxytran Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEY